JP2015193582A5 - - Google Patents

Download PDF

Info

Publication number
JP2015193582A5
JP2015193582A5 JP2014142910A JP2014142910A JP2015193582A5 JP 2015193582 A5 JP2015193582 A5 JP 2015193582A5 JP 2014142910 A JP2014142910 A JP 2014142910A JP 2014142910 A JP2014142910 A JP 2014142910A JP 2015193582 A5 JP2015193582 A5 JP 2015193582A5
Authority
JP
Japan
Prior art keywords
agent according
group
aging
anserine
carnosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014142910A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015193582A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014142910A priority Critical patent/JP2015193582A/ja
Priority claimed from JP2014142910A external-priority patent/JP2015193582A/ja
Priority to CN201580017212.3A priority patent/CN106413733A/zh
Priority to US15/129,602 priority patent/US20170165314A1/en
Priority to ES15768816T priority patent/ES2879329T3/es
Priority to SG10201808208PA priority patent/SG10201808208PA/en
Priority to KR1020227041506A priority patent/KR20220164079A/ko
Priority to EP15768816.9A priority patent/EP3124034B1/en
Priority to KR1020167030159A priority patent/KR20160146760A/ko
Priority to PCT/JP2015/056412 priority patent/WO2015146522A1/ja
Priority to SG11201608027RA priority patent/SG11201608027RA/en
Publication of JP2015193582A publication Critical patent/JP2015193582A/ja
Publication of JP2015193582A5 publication Critical patent/JP2015193582A5/ja
Priority to US15/877,304 priority patent/US20180140655A1/en
Pending legal-status Critical Current

Links

JP2014142910A 2014-03-28 2014-07-11 イミダゾールジペプチドを含む剤 Pending JP2015193582A (ja)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP2014142910A JP2015193582A (ja) 2014-03-28 2014-07-11 イミダゾールジペプチドを含む剤
SG11201608027RA SG11201608027RA (en) 2014-03-28 2015-03-04 Agent comprising imidazole dipeptide
EP15768816.9A EP3124034B1 (en) 2014-03-28 2015-03-04 Imidazole dipeptide for treating dementia due to aging or cerebral atrophy
US15/129,602 US20170165314A1 (en) 2014-03-28 2015-03-04 Agent containing imidazole dipeptide
ES15768816T ES2879329T3 (es) 2014-03-28 2015-03-04 Dipéptido imidazol para el tratamiento de la demencia debida al envejecimiento o la atrofia cerebral
SG10201808208PA SG10201808208PA (en) 2014-03-28 2015-03-04 Agent comprising imidazole dipeptide
KR1020227041506A KR20220164079A (ko) 2014-03-28 2015-03-04 이미다졸디펩티드를 포함하는 제제
CN201580017212.3A CN106413733A (zh) 2014-03-28 2015-03-04 包含咪唑二肽的试剂
KR1020167030159A KR20160146760A (ko) 2014-03-28 2015-03-04 이미다졸디펩티드를 포함하는 제제
PCT/JP2015/056412 WO2015146522A1 (ja) 2014-03-28 2015-03-04 イミダゾールジペプチドを含む剤
US15/877,304 US20180140655A1 (en) 2014-03-28 2018-01-22 Agent containing imidazole dipeptide

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014069103 2014-03-28
JP2014069103 2014-03-28
JP2014142910A JP2015193582A (ja) 2014-03-28 2014-07-11 イミダゾールジペプチドを含む剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019019712A Division JP6588666B2 (ja) 2014-03-28 2019-02-06 イミダゾールジペプチドを含む剤

Publications (2)

Publication Number Publication Date
JP2015193582A JP2015193582A (ja) 2015-11-05
JP2015193582A5 true JP2015193582A5 (enExample) 2017-08-17

Family

ID=54195052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014142910A Pending JP2015193582A (ja) 2014-03-28 2014-07-11 イミダゾールジペプチドを含む剤

Country Status (8)

Country Link
US (2) US20170165314A1 (enExample)
EP (1) EP3124034B1 (enExample)
JP (1) JP2015193582A (enExample)
KR (2) KR20160146760A (enExample)
CN (1) CN106413733A (enExample)
ES (1) ES2879329T3 (enExample)
SG (2) SG11201608027RA (enExample)
WO (1) WO2015146522A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6401028B2 (ja) * 2014-11-27 2018-10-03 Ｓｈｉｏｄａライフサイエンス株式会社 鯨筋肉抽出物からなる中長期記憶障害予防改善剤
JP6550357B2 (ja) * 2016-08-24 2019-07-24 日本ハム株式会社 イミダゾールジペプチドを含有する、グリア細胞における神経栄養因子等の遺伝子の発現誘導剤
JP7134607B2 (ja) * 2016-08-25 2022-09-12 大正製薬株式会社 錠剤
JP6510004B2 (ja) * 2016-11-15 2019-05-08 日本ハム株式会社 イミダゾールジペプチドを含有するエクソソーム調節剤、およびエクソソームを含有する神経細胞活性化剤
JP2018140958A (ja) * 2017-02-28 2018-09-13 国立大学法人 東京大学 ペリサイトの変成を抑制する剤
US11498048B2 (en) 2017-10-13 2022-11-15 W.M. Barr & Company, Inc. Composition containing urea for use in brine formation
JP7251036B2 (ja) * 2018-06-28 2023-04-04 ポーラ化成工業株式会社 皮膚老化改善剤のスクリーニング方法
JP7464945B2 (ja) * 2018-10-26 2024-04-10 国立大学法人 東京大学 抗酸化剤、抗糖化剤又は抗炎症剤
JP7321017B2 (ja) * 2019-07-17 2023-08-04 東海物産株式会社 機能性食品
CN115066273A (zh) * 2019-12-27 2022-09-16 三得利控股株式会社 包含环二肽、嘌呤核苷和/或氨基酸以及鸡提取物的组合物、其生产方法以及环二肽、嘌呤核苷和/或氨基酸及鸡提取物的用途
US20230024193A1 (en) * 2020-02-26 2023-01-26 The University Of Tokyo Transistor-type sensor
CA3218849A1 (en) * 2021-05-14 2022-11-17 University Of Rochester Variants of sirt6 for use in preventing and/or treating age-related diseases
KR102868976B1 (ko) * 2021-12-10 2025-11-03 (주)잇마플 생체이용율과 이미다졸 펩타이드가 증가된 수용성 닭가슴살 가수분해물 및 그 제조방법
WO2025104978A1 (ja) * 2023-11-13 2025-05-22 国立大学法人 東京大学 ネクロプトーシス制御剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960010020A (ko) * 1994-09-09 1996-04-20 도리이 신이치로 조혈 기능 항진제
ATE332127T1 (de) * 1994-11-08 2006-07-15 Avicena Group Inc Verwendung von kreatin oder kreatinanologen zur behandlung von huntington chorea, morbus parkinson und amyotrophen lateralsklerose
JP2000116987A (ja) 1998-10-15 2000-04-25 Sanyo Electric Co Ltd 洗剤溶かし装置およびこれを備えた洗濯機ならびに静止型溶解装置
JP4023648B2 (ja) 1999-01-13 2007-12-19 日本ハム株式会社 皮膚代謝促進物及び機能性食品
JP2003513039A (ja) * 1999-11-03 2003-04-08 ジュヴェノン インコーポレイテッド 良性の健忘症を治療する方法
KR20020044740A (ko) * 2000-12-06 2002-06-19 강경선 카노신을 유효성분으로 하는 세포예정사 관련 질환의 예방및 치료제
ATE328596T1 (de) * 2001-03-16 2006-06-15 Suntory Ltd Autonomsystem kontrollagentien und gesundheitsgetränke und -nahrungsmittel
US6498498B1 (en) * 2001-06-27 2002-12-24 Intel Corporation Apparatus and method for applying reciprocity to frequency-domain noise analysis
WO2003013514A1 (en) * 2001-08-08 2003-02-20 Carn-Aware Llc Improving neurological functions
US20060257502A1 (en) * 2005-05-11 2006-11-16 Jiankang Liu A combination of mitochondrial nutrients for relieving stress, preventing and improving stress-related disorders
JP2007070316A (ja) 2005-09-09 2007-03-22 Nippon Meat Packers Inc 経口用組成物及び栄養補助食品
WO2007116987A1 (ja) * 2006-03-31 2007-10-18 Nippon Meat Packers, Inc. 学習機能向上効果及び抗不安効果を有する機能性食品及び薬剤

Similar Documents

Publication Publication Date Title
JP2015193582A5 (enExample)
Catena-Dell’Osso et al. Inflammation, serotonin and major depression
JP2015503593A5 (enExample)
Permoda-Osip et al. Vitamin B12 level may be related to the efficacy of single ketamine infusion in bipolar depression
Fiala et al. Modulation of innate immunity of patients with Alzheimer’s disease by omega-3 fatty acids
JP2017528483A5 (enExample)
JP2017519807A5 (enExample)
JP2011190199A (ja) 関節リウマチ薬
CN110248646A (zh) 包含吡非尼酮的缓释组合物用于治疗和逆转人脂肪性肝炎(nafld/nash)的药物用途
JP2017533220A5 (enExample)
RU2016149316A (ru) Лечение ревматоидного артрита
JP2017508737A5 (enExample)
JP2016520114A5 (enExample)
JP6154029B2 (ja) 睡眠改善剤、ノンレム睡眠時間増加剤及び鎮静剤
Cobos et al. A case of exuberant candidal onychomycosis in a child with hyper IgE syndrome
Tanaka et al. Environment, the immune system, and depression: an integrative review and discussion of the infection-defense hypothesis
Al Nasrallah et al. The use of dexmedetomidine for longer than 48 hours with evaluation of its secondary outcome in patients with liver disease
JP2015040204A (ja) 運動機能性向上剤
Omran et al. Rubinstein-Taybi Syndrome; A Case Report.
Ezzati Time-restricted eating on inflammation and oxidative stress in overweight, older adults
Weiner Valproic acid
Terki K et al. Influence of bimaxillary protrusion on the perception of smile esthetics
Wehrmacher et al. Constructive Development of Aging
Sari A case of phagophobia
Demoralization et al. Helplessness and personal failure. Subjective incompetence. Loss of meaning and purpose in life. Social alienation. Different from depression because there is as a sense of subjective failure to achieve life's goals. In older patients*: Despair and angst associated with loss of purpose and meaning to life.·• Loss of relationships.